(¿Â¶óÀÎ) Á¦35Â÷ ´ëÇѺÎÀÎÁ¾¾çÇÐȸ Ãá°èÇмú´ëȸ : 2020-08-01±³À°ÀÏÀÚ : 2020-08-01
±³À°Àå¼Ò : ¿Â¶óÀÎ ¿¬¼ö±³À° (½Ç½Ã°£ È»ó°ÀÇ/¿Ü±¹ÀÎ ¿¬ÀÚ ³ìÈ°¿¬ ¿µ»ó ¼ÛÃâ)
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) Á¦35Â÷ ´ëÇѺÎÀÎÁ¾¾çÇÐȸ Ãá°èÇмú´ëȸ ÁÖÃÖ±â°ü : ´ëÇѺÎÀÎÁ¾¾çÇÐȸ
´ã´çÀÚ : ÇѼ¼¹Ì
¿¬¶ôó : 02-512-0040
À̸ÞÀÏ :
gyncancer@gyncancer.or.kr ±³À°Á¾·ù : »êºÎÀΰú
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 10 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 60,000¿ø
ºñ°í Àü¹®ÀÇ: 60,000 / Àü°øÀÇ: 45,000 / ¿¬±¸¿ø,°£È£»ç: 30,000 / ÁÂÀå,¿¬ÀÚ, ¸¸65¼¼ÀÌ»ó: ¹«·á
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 08¿ù 01ÀÏ E-Conference 09:00~09:10 Opening Remarks ±è½Âö(´ëÇѺÎÀÎÁ¾¾çÇÐȸ ȸÀå)
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 09:10~09:25 COVID-19 & gyn cancer: management and research status ½Å¼ÒÁø(°è¸íÀÇ´ë)
Åä·Ð 08¿ù 01ÀÏ E-Conference 09:25~09:30 Discussion ()
Åä·Ð 08¿ù 01ÀÏ E-Conference 09:30~10:30 [6 topics] - 10min / 1topic (each: 8min presentation / 2min discussion) ()
ÈÞ½Ä 08¿ù 01ÀÏ E-Conference 10:30~10:50 Coffee Break ()
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 10:50~11:10 Controversial issues in gynaecological oncology Neville Hacker(Univ. of NSW Australia)
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 11:10~11:30 Molecular and endocrine-targeted therapeutic options for endometrial cancer Hidetaka Katabuchi(Kumamoto Univ. Japan)
Åä·Ð 08¿ù 01ÀÏ E-Conference 11:30~11:40 Discussion ()
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 11:40~12:00 Are we about to cure ovarian cancer Mansoor Raza Mirza(Copenhagen Univ. Denmark)
½Ä»ç 08¿ù 01ÀÏ E-Conference 12:00~13:30 Lunch ()
Åä·Ð 08¿ù 01ÀÏ E-Conference 13:30~15:00 (9 topics) - 10min/1topic (each: 8min presentation / 2min discussion) ()
ÈÞ½Ä 08¿ù 01ÀÏ E-Conference 15:00~15:20 Coffee Break ()
Åä·Ð 08¿ù 01ÀÏ E-Conference 15:20~16:30 (7 topics) - 10min/1topic (each: 8min presentation / 2min discussion) ()
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 16:30~16:45 Cervical cancer À̱ÙÈ£(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 16:45~17:00 Endometrial cancer ±è´ë¿¬(¿ï»êÀÇ´ë)
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 17:00~17:15 Ovarian cancer Àå¼®ÁØ(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 17:15~17:30 Cervical cancer screening ÀÌÅûó(¼¿ïÀÇ´ë)
Åä·Ð 08¿ù 01ÀÏ E-Conference 17:30~17:45 Discussion ()
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 11:40~12:00 Prevention of chemotherapy-induced nausea and vomiting (CINV), NOT treatment ÃÖ¹Îö(Â÷ÀÇ´ë)
½Ä»ç 08¿ù 01ÀÏ E-Conference 12:00~13:30 Lunch ()
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 13:30~13:50 Surgical principles and tips to avoid complications ±èÀ±È¯(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 13:50~14:10 Bowel complications ÇãÇõ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 14:10~14:30 Urologic complications ±è¼±ÀÏ(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 14:30~14:50 Vascular complications È«ÁØÈ(Áß¾ÓÀÇ´ë)
Åä·Ð 08¿ù 01ÀÏ E-Conference 14:50~15:00 Discussion ()
ÈÞ½Ä 08¿ù 01ÀÏ E-Conference 15:00~15:20 Coffee Break ()
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 15:20~15:35 Predictive model for lymph node metastasis using PET/CT and sentinel node mapping in endometrial cancer ÀÓö±Ç(¿ï»êÀÇ´ë)
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 15:35~15:50 Comparison of tumor-infiltrating lymphocytes according to BRCA1/2 status in patients with serous ovarian cancer ¹ÚÁؽÄ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 15:50~16:05 Validation of potential protein markers predicting chemoradioresistance in early cervical cancer by immunohistochemical staining Á¤¼ö¿µ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 16:05~16:20 Peripheral blood BRCA1 methylation profiling to predict family ovarian cancer Á¤À¯¿¬(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 16:20~17:00 Meta-analysis ³í¹®¾²±â I: ³í¹®°Ë»öºÎÅÍ Åë°è ºÐ¼® ¿ø¸®±îÁö À̹æÇö(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 08¿ù 01ÀÏ E-Conference 17:00~17:40 Meta-analysis ³í¹®¾²±â II: Åë°èºÐ¼® ½ÇÁ¦¿Í ÃâÆÇ³í¹® ¿¹½Ã ±èÈñ½Â(¼¿ïÀÇ´ë)
Åä·Ð 08¿ù 01ÀÏ E-Conference 17:40~17:45 Discussion ()
±âŸ 08¿ù 01ÀÏ E-Conference 17:45~18:00 ½Ådzȣ¿ùÇмú»ó ½Ã»ó ()